Compliance: clear communication's critical.
作者信息
Buller A J, Connell B, Spencer A F
出版信息
Br J Ophthalmol. 2005 Oct;89(10):1370. doi: 10.1136/bjo.2005.066175.
Abstract
摘要
相似文献
1
Compliance: clear communication's critical.
Br J Ophthalmol. 2005 Oct;89(10):1370. doi: 10.1136/bjo.2005.066175.
2
Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice.
Ophthalmology. 2009 Dec;116(12):2277-85.e1-3. doi: 10.1016/j.ophtha.2009.04.052. Epub 2009 Sep 10.
3
Patient-centered communication to assess and enhance patient adherence to glaucoma medication.
Ophthalmology. 2009 Nov;116(11 Suppl):S37-42. doi: 10.1016/j.ophtha.2009.06.023.
4
[Compliance in glaucoma].
Oftalmologia. 2008;52(3):7-9.
5
Introduction: new insights on enhancing adherence to topical glaucoma medications.
Ophthalmology. 2009 Nov;116(11 Suppl):S29. doi: 10.1016/j.ophtha.2009.06.026.
6
Glaucoma medications. How to improve compliance and adherence.
Insight. 2012 Spring;37(2):5-9; quiz 10.
7
[Compliance and ignorance in glaucoma in Romanian patients].
Oftalmologia. 2009;53(3):130-3.
8
Medication adherence in glaucoma: approaches for optimizing patient compliance.
Curr Opin Ophthalmol. 2006 Apr;17(2):190-5. doi: 10.1097/01.icu.0000193078.47616.aa.
9
Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
Ophthalmology. 2008 Aug;115(8):1320-7, 1327.e1-3. doi: 10.1016/j.ophtha.2007.11.023. Epub 2008 Mar 5.
10
A clinician's guide to the assessment and management of nonadherence in glaucoma.
Ophthalmology. 2009 Nov;116(11 Suppl):S43-7. doi: 10.1016/j.ophtha.2009.06.022.
引用本文的文献
1
Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review.
J Clin Med. 2022 Dec 24;12(1):151. doi: 10.3390/jcm12010151.
2
Compliance in usage of low-dose atropine for prevention of progression of myopia in Indian children.
Indian J Ophthalmol. 2021 Aug;69(8):2230-2231. doi: 10.4103/ijo.IJO_3354_20.
3
Patient-Physician Communication on Medication Cost during Glaucoma Visits.
Optom Vis Sci. 2017 Dec;94(12):1095-1101. doi: 10.1097/OPX.0000000000001139.
4
Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.
Ophthalmology. 2015 Apr;122(4):748-54. doi: 10.1016/j.ophtha.2014.11.001. Epub 2014 Dec 24.
5
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus.
Patient Prefer Adherence. 2014 Jun 12;8:853-64. doi: 10.2147/PPA.S53162. eCollection 2014.
6
Electronic compliance monitoring of topical treatment after ophthalmic surgery.
Int Ophthalmol. 2010 Aug;30(4):385-90. doi: 10.1007/s10792-010-9362-3. Epub 2010 Apr 7.
7
Microprocessor controlled compliance monitor for eye drop medication.
Br J Ophthalmol. 2006 Jul;90(7):830-2. doi: 10.1136/bjo.2005.088526. Epub 2006 Mar 15.
本文引用的文献
1
Patient persistency with topical ocular hypotensive therapy in a managed care population.
Am J Ophthalmol. 2004 Jan;137(1 Suppl):S3-12. doi: 10.1016/j.ajo.2003.10.035.
2
Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucoma.
Am J Ophthalmol. 2004 Jan;137(1 Suppl):S1-2. doi: 10.1016/j.ajo.2003.10.029.
3
Compliance with treatment of patients with chronic open-angle glaucoma.
Br J Ophthalmol. 1983 Jan;67(1):46-9. doi: 10.1136/bjo.67.1.46.
Zotero 插件